Mortality among persons with a history of Kawasaki disease in Japan: Can paediatricians safely discontinue follow-up of children with a history of the disease but without cardiac sequelae?

Acta Paediatrica, International Journal of Paediatrics

Volumn 94, Issue 4, 2005, Pages 429-434

  Nakamura, Yosikazu ^a   Aso, Eiko ^a   Yashiro, Mayumi ^a   Uehara, Ritei ^a   Watanabe, Makoto ^a   Tajimi, Morihiro ^a   Oki, Izumi ^a   Ojima, Toshiyuki ^a   Yanagawa, Hiroshi ^b   Kawasaki, Tomisaku ^c  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b SAITAMA PREFECTURAL UNIVERSITY   (Japan)

^c Kawasaki Disease Research Center   (Japan)

Author keywords

Follow up; Long term prognosis; Mortality rate; Mucocutaneous lymph node syndrome

Indexed keywords

ARTICLE; CAUSE OF DEATH; CHILD; CLINICAL ARTICLE; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; HEART DISEASE; HUMAN; INCIDENCE; INFANT; JAPAN; MALE; MORTALITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEWBORN; PEDIATRICIAN; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE;

CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PROGNOSIS; SEX FACTORS;

EID: 20144389875     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035250510025888     Document Type: Article

References (24)

1. Nakamura Y, Yanagawa H, Kawasaki T. Mortality among children with Kawasaki disease in Japan. N Engl J Med 1992;326:1246-9.
2. Nakamura Y, Yanagawa H, Kato H, Kawasaki T, the Kawasaki Disease Follow-up Group. Mortality rates for patients with a history of Kawasaki disease in Japan. J Pediatr 1996;128:75-81.
3. Nakamura Y, Yanagawa H, Kato H, Harada K, Kawasaki T, the Kawasaki Disease Follow-up Group. Mortality among patients with a history of Kawasaki disease: The third look. Acta Paediatr Jpn 1998;40:419-23.
4. Nakamura Y, Yanagawa H, Harada K, Kato H, Kawasaki T. Mortality among persons with a history of Kawasaki disease in Japan: Existence of cardiac sequelae elevated the mortality. J Epidemiol 2000;10:372-5.
5. Nakamura Y, Yanagawa H, Harada K, Kato H, Kawasaki T. Mortality among persons with a history of Kawasaki disease: the fifth look. Arch Pediatr Asolesc Med 2002;156:162-5.
6. Sasaguri Y, Kato H. Regression of aneurysms in Kawasaki disease: a pathological study. J Pediatr 1982;100:225-31.
7. Tanaka N, Naoe S, Masuda H, Ueno T. Pathological study of sequelae of Kawasaki disease (MCLS): with special reference to the heart and coronary arterial lesions. Acta Pathol Jpn 1986;36:1513-27.
8. Naoe S, Takahashi K, Masuda H, Tanaka N. Kawasaki disease: with particular emphasis on arterial lesions. Acta Pathol Jpn 1991;41:785-97.
9. Lang B, Duffy CM. Controversies in the management of Kawasaki disease. Best Pract Res Clin Pheumatol 2002;3: 427-42.
10. Dajani AS, Taubert KA, Takahashi M, Bierman FZ, Freed MD, Ferrieri P, et al. Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1994;89:916-22.
11. McMorrow-Tuohy AM, Tani LY, Cetta F, Lewin AB, Eidem BW, Van Buren P, et al. How many echocardiograms are necessary for follow-up evaluation of patients with Kawasaki disease? Am J Cardiol 2001;88:328-30.
12. Brogan PA, Bose A, Burgner D, Shingadia D, Tulloh R, Michie C, et al. Kawasaki disease: an evidence-based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child 2002;86:286-90.
13. Suzuki A, Kamiya T, Ono Y, Kohata T, Kimura K, Takamiya M. Follow-up study of coronary artery lesions due to Kawasaki disease by serial selective coronary arteriography in 200 patients. Heart Vessels 1987;3:159-65.
14. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease: a 10- to 21-year follow-up study of 594 patients. Circulation 1996; 94:1379-85.
15. Fukushige J, Takahashi N, Ueda K, Hijii T, Igarashi H, Ohshima A. Long-term outcome of coronary abnormalities in patients after Kawasaki disease. Pediatr Cardiol 1996;17:71-6.
16. Iemura M, Ishii M, Sugimura T, Akagi T, Kato H. Long-term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function. Heart 2000; 83:307-11.
17. Yanagawa H, Kawasaki T, Shigematsu I. Nationwide survey on Kawasaki disease in Japan. Pediatrics 1987;80:58-62.
18. MacMahon B, Pugh TF. Epidemiology: principles and methods. 1st ed. Boston: Little, Brown and Company; 1970. p. 99.
19. Yanagawa H, Nakamura Y, Yashiro M, Ojima T, Koyanagi H, Kawasaki T. Update of the epidemiology of Kawasaki disease in Japan: from the results of 1993-94 nationwide survey. J Epidemiol 1996;6:148-57.
20. Rosner B. Fundamentals of biostatistics. 5th ed. Pacific Grove, CA: Duxbury; 2000. p. 196-201.
21. Yanagawa H, Nakamura Y, Yashiro M, Ojima T, Tanihara S, Oki I, et al. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Pediatrics 1998;102:e65.
22. Muta H, Ishii M, Matsuishi T. Coronary artery aneurysms after Kawasaki disease in a patient with a single coronary artery. Pediatr Cardiol 2002;23:568-9.
23. Takahashi T, Sato S, Ichinose K, Oura H, Koda M, Sato T, et al. Clinical study on Kawasaki disease in patients with congenital heart disease. Shonika Rinsho (Jpn J Pediatr) 1996; 49:2039-44 [in Japanese].
24. Murray JC, Bomgaars LR, Carcamo B, Mahoney DH Jr. Lymphoid malignancies following Kawasaki disease. Am J Hematol 1995;50:299-300.